Literature DB >> 11753646

Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas.

W Chen1, N Palanisamy, H Schmidt, J Teruya-Feldstein, S C Jhanwar, A D Zelenetz, J Houldsworth, R S Chaganti.   

Abstract

We report here the molecular cloning and characterization of a t(1;14)(q21;q32) in a follicular lymphoma (FL) with an unusual BCL2 aberration. Fluorescence in situ hybridization (FISH) and Southern blot analysis of tumor cells identified the translocation breakpoint within the 5' switch region of IGHG (Sgamma). We cloned the chimeric breakpoint region approximately 1.5 kbp downstream from the HindIII site of 5'Sgamma2 on chromosome 14q32 and identified a 360-bp novel segment with homology to the CpG island clone 11h8. Two BAC clones containing this sequence were isolated and mapped to 1q21 by FISH. BAC 342/P13 contained sequences homologous to Fcgamma receptors 2A, 3A, 2B, 3B, and a heat shock protein gene HSP70B. The translocation brought the Sgamma2 region of a productive IGH allele 20 approximately 30 kbp upstream of FCGR2B. As a result of the translocation, the b2 isoform of FCGR2B was overexpressed in the tumor. Screening of a panel of 76 B-cell lymphomas with 1q21-23 cytogenetic aberrations by Southern blot analysis using breakpoint probes identified an additional FL with a t(14;18)(q32;q21) and a breakpoint in the FCGR2B region. These results suggest that FCGR2B may be deregulated by 1q21 aberration in BCL2 rearranged FLs and possibly play a role in their progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11753646     DOI: 10.1038/sj.onc.1204989

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Three major uncertainties in the antibody therapy of cancer.

Authors:  George T Stevenson
Journal:  Haematologica       Date:  2014-10       Impact factor: 9.941

2.  Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Authors:  Markus Riester; Lillian Werner; Joaquim Bellmunt; Shamini Selvarajah; Elizabeth A Guancial; Barbara A Weir; Edward C Stack; Rachel S Park; Robert O'Brien; Fabio A B Schutz; Toni K Choueiri; Sabina Signoretti; Josep Lloreta; Luigi Marchionni; Enrique Gallardo; Federico Rojo; Denise I Garcia; Yvonne Chekaluk; David J Kwiatkowski; Bernard H Bochner; William C Hahn; Azra H Ligon; Justine A Barletta; Massimo Loda; David M Berman; Philip W Kantoff; Franziska Michor; Jonathan E Rosenberg
Journal:  Clin Cancer Res       Date:  2014-01-31       Impact factor: 12.531

3.  Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

Authors:  Ichiro Hanamura; James P Stewart; Yongsheng Huang; Fenghuang Zhan; Madhumita Santra; Jeffrey R Sawyer; Klaus Hollmig; Maurizio Zangarri; Mauricio Pineda-Roman; Frits van Rhee; Federica Cavallo; Bart Burington; John Crowley; Guido Tricot; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

Review 4.  Fc gamma receptors and cancer.

Authors:  Lydie Cassard; Joël Cohen-Solal; Sophie Camilleri-Broët; Emilie Fournier; Wolf Herman Fridman; Catherine Sautès-Fridman
Journal:  Springer Semin Immunopathol       Date:  2006-11-10

5.  Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Authors:  Jun Inoue; Takemi Otsuki; Akira Hirasawa; Issei Imoto; Yoshinobu Matsuo; Shiroh Shimizu; Masafumi Taniwaki; Johji Inazawa
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

Review 6.  Inhibitory Fc gamma receptors: from gene to disease.

Authors:  Radu N Stefanescu; Mikhail Olferiev; Yi Liu; Luminita Pricop
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

7.  Transcriptional network analysis reveals that AT1 and AT2 angiotensin II receptors are both involved in the regulation of genes essential for glioma progression.

Authors:  Hátylas Azevedo; André Fujita; Silvia Yumi Bando; Priscila Iamashita; Carlos Alberto Moreira-Filho
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

8.  S100A11 is a migration-related protein in laryngeal squamous cell carcinoma.

Authors:  Chengyu Wang; Zhenwei Zhang; Li Li; Jianpeng Zhang; Jiasen Wang; Jingping Fan; Binghua Jiao; Shuwei Zhao
Journal:  Int J Med Sci       Date:  2013-09-06       Impact factor: 3.738

9.  Yin Yang gene expression ratio signature for lung cancer prognosis.

Authors:  Wayne Xu; Shantanu Banerji; James R Davie; Fekadu Kassie; Douglas Yee; Robert Kratzke
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

10.  Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma.

Authors:  Sarah E Arthur; Aixiang Jiang; Bruno M Grande; Miguel Alcaide; Razvan Cojocaru; Christopher K Rushton; Anja Mottok; Laura K Hilton; Prince Kumar Lat; Eric Y Zhao; Luka Culibrk; Daisuke Ennishi; Selin Jessa; Lauren Chong; Nicole Thomas; Prasath Pararajalingam; Barbara Meissner; Merrill Boyle; Jordan Davidson; Kevin R Bushell; Daniel Lai; Pedro Farinha; Graham W Slack; Gregg B Morin; Sohrab Shah; Dipankar Sen; Steven J M Jones; Andrew J Mungall; Randy D Gascoyne; Timothy E Audas; Peter Unrau; Marco A Marra; Joseph M Connors; Christian Steidl; David W Scott; Ryan D Morin
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.